Home » Newsletters » BioWorld Science

BioWorld Science

March 14, 2003

View Archived Issues

Agents for leishmaniasis prepared and tested by Spanish team

New hypolipidemic and hypocholesterolemic agents identified by Indian researchers

New iminosugars with utility in viral infections and cancer and as immunostimulants

Schering researchers identify new urea-based NPY Y5 antagonists

Karo Bio patents new inhibitors of IK channels and their use in atrial fibrillation

Amgen researchers present new MC4 receptor agonists

Improved plasma lipid profile on ezetimibe plus lovastatin in primary hypercholesterolemia

Acambis to market Cangene's VIG product outside North America and Israel

Liposomal budesonide reduces lung inflammation in an experimental model of asthma

Kosan Biosciences receives SBIR grant to develop production method for laulimalide

Entomed and Naeja enter screening agreement for infectious diseases and cancer

Watson files Oxytrol MAA in Europe

Lorus allowed U.S. patent that protects key antisense target

Endovasc files phase III protocols for Liprostin

Interferon Sciences sells Alferon N Injection to HemispheRx

Urea-based HIV protease inhibitors identified by Pharmacor researchers

Elan and Lilly claim novel inhibitors of Abeta synthesis and/or release

Phase II/III oxypurinol study begins dosing

Patient recruitment completed in phase IIb trial of ATL-962 for obesity

Shire to develop extended-release trospium

OSI to market Novantrone in oncology indications

Enanta earns milestone in Chiron hepatitis C collaboration

Teva invests in Gamida-Cell

Micrologix Biotech updates development activities

New immunosuppressive agents isolated from soil microorganism at Japanese lab

Kaken discovers novel antifungal/cytotoxic antibiotic during screening of microbial metabolites

U.S. patent covers Chiron's NAT methods for HIV-1

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...